Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription


1 Ann Neurol
1 Brain Res
1 Int J Neurosci
1 J Neurochem
1 J Neurol Neurosurg Psychiatry
1 Mov Disord
1 Nat Rev Neurol
1 Neurobiol Dis
2 Neurologia (Engl Ed)
3 Neurology
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Neurol

  1. RASCHELLA F, Scafa S, Puiatti A, Martin Moraud E, et al
    Actigraphy enables home screening of REM behavior disorder in Parkinson disease.
    Ann Neurol. 2022 Oct 4. doi: 10.1002/ana.26517.
    PubMed         Abstract available

    Brain Res

  2. XIE J, Li T, He T, Xu R, et al
    Deep brain stimulation on the external segment of the globus pallidus improves the electrical activity of internal segment of globus pallidus in a rat model of Parkinson's disease.
    Brain Res. 2022 Oct 3:148115. doi: 10.1016/j.brainres.2022.148115.
    PubMed         Abstract available

    Int J Neurosci

  3. OZDILEK B, Agirbasli M
    Soluble LRP-1 in Parkinson's disease: clues for paradoxical effects.
    Int J Neurosci. 2022 Oct 3:1-12. doi: 10.1080/00207454.2022.2131552.
    PubMed         Abstract available

    J Neurochem

  4. SANTORO M, Fadda P, Klephan KJ, Hull C, et al
    Neurochemical, histological and behavioral profiling of the acute, sub-acute and chronic MPTP mouse model of Parkinson's disease.
    J Neurochem. 2022 Oct 3. doi: 10.1111/jnc.15699.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  5. KREMER NI, van Laar T, Lange SF, Statius Muller S, et al
    STN-DBS electrode placement accuracy and motor improvement in Parkinson's disease: systematic review and individual patient meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Oct 7. pii: jnnp-2022-329192.
    PubMed         Abstract available

    Mov Disord

    LRRK2 PROTAC Degraders as a Potential Novel Targeting Strategy for Parkinson's Disease?
    Mov Disord. 2022 Oct 5. doi: 10.1002/mds.29243.

    Nat Rev Neurol

    Transmembrane protein interacts with alpha-synuclein to confer risk of PD.
    Nat Rev Neurol. 2022;18:576.

    Neurobiol Dis

  8. MARTEL AC, Galvan A
    Connectivity of the corticostriatal and thalamostriatal systems in normal and parkinsonian states: An update.
    Neurobiol Dis. 2022;174:105878.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  9. GHOSH R, Ray A, Roy D, Das S, et al
    Parkinsonism with akinetic mutism following osmotic demyelination syndrome in a SARS-CoV-2 infected elderly diabetic woman: A case report.
    Neurologia (Engl Ed). 2022;37:706-708.

    Is there a halo-enzymopathy in Parkinson's disease?
    Neurologia (Engl Ed). 2022;37:661-667.
    PubMed         Abstract available


  11. PRASUHN J, Gottlich M, Ebeling B, Kourou S, et al
    Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31P-MRSI.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201288.
    PubMed         Abstract available

  12. CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al
    Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201269.
    PubMed         Abstract available

  13. PORTUGAL B, Artaud F, Domenighetti C, Roze E, et al
    Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study.
    Neurology. 2022 Oct 3. pii: WNL.0000000000201468.
    PubMed         Abstract available

    PLoS One

  14. DAS J, Morris R, Barry G, Vitorio R, et al
    Exploring the feasibility of technological visuo-cognitive training in Parkinson's: Study protocol for a pilot randomised controlled trial.
    PLoS One. 2022;17:e0275738.
    PubMed         Abstract available

  15. BARCENAS R, Fuentes-Garcia R, Naranjo L
    Mixed kernel SVR addressing Parkinson's progression from voice features.
    PLoS One. 2022;17:e0275721.
    PubMed         Abstract available

  16. RAZALI K, Mohd Nasir MH, Othman N, Doolaanea AA, et al
    Characterization of neurobehavioral pattern in a zebrafish 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced model: A 96-hour behavioral study.
    PLoS One. 2022;17:e0274844.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.